Meanwhile, some latest hypothesizes also support this conclusion that angiotensin receptor 1 (AT1R) inhibitors might be beneficial for pneumonia patients infected by COVID‐19 (Gurwitz, 2020). Here, AGTR1 is linked to COVID-19.